Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle. 2004

Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
Nutrition/Infection Unit, Department of Family Medicine and Community Health, Tufts University School of Medicine, Boston, Massachusetts 02111, USA. junaidah.barnett@tufts.edu

Estrogen levels are higher during the luteal compared with the follicular phase of the menstrual cycle. It was hypothesized that the luteal compared with the follicular phase has a lipid and lipoprotein profile associated with decreased coronary heart disease (CHD) risk. This was tested using well-defined data from healthy, well-characterized premenopausal Caucasian women under very controlled metabolic conditions. The percent differences in lipid, lipoprotein, and sex hormone levels between the follicular and luteal phases were estimated using generalized estimating equations after adjusting for age, body mass index, calendar time, and season. The low-density lipoprotein cholesterol (LDL-C) level was 6.2% lower (P = 0.015), and the total cholesterol/high-density lipoprotein cholesterol (HDL-C) and LDL-C/HDL-C ratios were 5.1% (P = 0.0006) and 8.4% (P = 0.002) lower, respectively, during the luteal phase. Levels of estradiol and other estrogens were significantly higher (by>100% each; P < 0.0001 in all cases) in the luteal phase. These findings support the study hypothesis. Fluctuations in levels of LDL-C and the total cholesterol/HDL-C and LDL-C/HDL-C ratios between menstrual cycle phases need to be considered in the screening and medical monitoring of premenopausal women, especially those with borderline levels. Although small, such fluctuations may prove to be clinically significant in the long run. Studies involving premenopausal women need to more clearly define and validate menstrual cycle phase in the design and interpretation of study results.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008183 Luteal Phase The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION. Menstrual Cycle, Luteal Phase,Menstrual Cycle, Secretory Phase,Menstrual Secretory Phase,Postovulatory Phase,Phase, Luteal,Phase, Postovulatory,Secretory Phase, Menstrual
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D005498 Follicular Phase The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION. Menstrual Cycle, Follicular Phase,Menstrual Cycle, Proliferative Phase,Menstrual Proliferative Phase,Preovulatory Phase,Phase, Follicular,Phase, Menstrual Proliferative,Phase, Preovulatory,Proliferative Phase, Menstrual

Related Publications

Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
October 1994, Ginekologia polska,
Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
April 2020, Medicine and science in sports and exercise,
Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
March 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
December 1977, Revista espanola de fisiologia,
Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
April 2011, European journal of obstetrics, gynecology, and reproductive biology,
Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
May 2010, Sleep,
Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
May 2017, Journal of clinical and diagnostic research : JCDR,
Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
January 1996, Psychological medicine,
Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
February 2002, Psychopharmacology,
Junaidah B Barnett, and Margo N Woods, and Stefania Lamon-Fava, and Ernst J Schaefer, and Judith R McNamara, and Donna Spiegelman, and Ellen Hertzmark, and Barry Goldin, and Christopher Longcope, and Sherwood L Gorbach
August 1999, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Copied contents to your clipboard!